Congratulations to Dr. Rudra Palash Mukherjee, a former graduate student of our collaborator Dr. Beitle and a student intern for Boston Mountain Biotech. Rudra was selected as one of the four finalists for the Millipore Sigma’s 2016 Life Science Award in Bioseparations for his innovative research towards the development of a recombinant peptide production and purification platform.
The National Science Foundation (NSF) has awarded Boston Mountain Biotech a Phase I STTR (small business technology transfer) commercialization grant for the “Harnessing CRISPR-mediated silencing for the one-step optimization of protein production strains”.Continue Reading
Author Angela De Palma, Ph.D. of GEN News recently highlighted the growing practice of using genetic engineering to improve pharmaceutical manufacturing productivity. Her article, in particular, focuses on the genetic engineering of Chinese Hamster Ovary (CHO) cells for the production of recombinant proteins. Continue Reading
Congratulations to Dr. Brune for being selected as a finalist for the Cartier Women’s Initiative Awards. The Cartier Women’s Initiative is an international business plan competition created in 2006 to identify, support and encourage projects by women entrepreneurs. Brune, 28, is one of 18 women in the world who have been selected as finalists for the Cartier Women’s Initiative Awards. Continue Reading
Are you an intellectual property manager or the founder of a new start-up? By providing early stage commercialization assessments, BMB can help you determine the patentability and marketability of your technologies, which can both save you money and increase your rate of licensing.
BMB’s first patent, titled “Separatome-based protein expression and purification platform” (US8927231) was issued today. This patent protects our Lotus® E. coli manufacturing platform and the production and purification of recombinant proteins. We are very excited to achieve this milestone in the development of our Lotus® Platform technology and anticipate more patents to be awarded in the years to come.
We are celebrating at BMB today! We have just received a Notice of Allowance from the USPTO in connection with our application Serial Number 14/056,747. This application covers our Lotus™ E. coli cell lines and the production and purification of recombinant proteins, including both therapeutic proteins and enzymes, from these cells. We expect that this is the first of many patents on our ground breaking Lotus™ expression and purification platform.
The Journal of Biotechnology has recently published an article discussing the work leading up to the development BMB’s separatome platform. The work focuses on the modification of a known IMAC HCP contaminant such that the protein no longer binds to IMAC resin. Check out the full article here.
Congratulations to both the University of Arkansas and the University of Pittsburgh for being ranked #68 and #33 respectively in the Intellectual Property Owners’ (IPO) recently published list of the top 100 universities worldwide granted U.S. patents in 2013. BMB is proud to be continuing our work to support the actions of both universities in the IP space.